Participating in a clinical trial can be a way to benefit from a treatment that is better than the current standard-of-care for any stage of cancer.
Changes that have been made to cancer clinical trials during the pandemic have greatly increased flexibility for participants and experts recommend they become permanent.
When consumers have a better understanding of how clinical trials work they are most likely to say they would enroll in one, a recent study found.
How could sharing of data among researchers conducting clinical trials lead to better progress against cancer and more benefit for patients?
In “adaptive” clinical trial design, the goal is to identify as rapidly as possible new drug therapies that show a likelihood of being successful in specific patient populations.